209 related articles for article (PubMed ID: 30297810)
1. Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer.
Chen F; Ma K; Madajewski B; Zhuang L; Zhang L; Rickert K; Marelli M; Yoo B; Turker MZ; Overholtzer M; Quinn TP; Gonen M; Zanzonico P; Tuesca A; Bowen MA; Norton L; Subramony JA; Wiesner U; Bradbury MS
Nat Commun; 2018 Oct; 9(1):4141. PubMed ID: 30297810
[TBL] [Abstract][Full Text] [Related]
2. Development of
Rainone P; Riva B; Belloli S; Sudati F; Ripamonti M; Verderio P; Colombo M; Colzani B; Gilardi MC; Moresco RM; Prosperi D
Int J Nanomedicine; 2017; 12():3447-3461. PubMed ID: 28496321
[TBL] [Abstract][Full Text] [Related]
3. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
[TBL] [Abstract][Full Text] [Related]
4. Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency.
Bruniaux J; Allard-Vannier E; Aubrey N; Lakhrif Z; Ben Djemaa S; Eljack S; Marchais H; Hervé-Aubert K; Chourpa I; David S
Int J Pharm; 2019 Oct; 569():118572. PubMed ID: 31352052
[TBL] [Abstract][Full Text] [Related]
5. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
[TBL] [Abstract][Full Text] [Related]
6. HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells.
Yamaguchi H; Hayama K; Sasagawa I; Okada Y; Kawase T; Tsubokawa N; Tsuchimochi M
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562708
[TBL] [Abstract][Full Text] [Related]
7. Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.
Li J; Xu W; Yuan X; Chen H; Song H; Wang B; Han J
Int J Nanomedicine; 2017; 12():6909-6921. PubMed ID: 29075110
[TBL] [Abstract][Full Text] [Related]
8. Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
Alric C; Hervé-Aubert K; Aubrey N; Melouk S; Lajoie L; Même W; Même S; Courbebaisse Y; Ignatova AA; Feofanov AV; Chourpa I; Allard-Vannier E
J Nanobiotechnology; 2018 Feb; 16(1):18. PubMed ID: 29466990
[TBL] [Abstract][Full Text] [Related]
9. Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.
Mu Q; Kievit FM; Kant RJ; Lin G; Jeon M; Zhang M
Nanoscale; 2015 Nov; 7(43):18010-4. PubMed ID: 26469772
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
11. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
[TBL] [Abstract][Full Text] [Related]
12. Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.
Vaneycken I; Devoogdt N; Van Gassen N; Vincke C; Xavier C; Wernery U; Muyldermans S; Lahoutte T; Caveliers V
FASEB J; 2011 Jul; 25(7):2433-46. PubMed ID: 21478264
[TBL] [Abstract][Full Text] [Related]
13. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles.
Girgis MD; Federman N; Rochefort MM; McCabe KE; Wu AM; Nagy JO; Denny C; Tomlinson JS
J Surg Res; 2013 Nov; 185(1):45-55. PubMed ID: 23827791
[TBL] [Abstract][Full Text] [Related]
14. Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.
Keyaerts M; Xavier C; Heemskerk J; Devoogdt N; Everaert H; Ackaert C; Vanhoeij M; Duhoux FP; Gevaert T; Simon P; Schallier D; Fontaine C; Vaneycken I; Vanhove C; De Greve J; Lamote J; Caveliers V; Lahoutte T
J Nucl Med; 2016 Jan; 57(1):27-33. PubMed ID: 26449837
[TBL] [Abstract][Full Text] [Related]
15. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
16. Targeted imaging and targeted therapy of breast cancer cells via fluorescent double template-imprinted polymer coated silicon nanoparticles by an epitope approach.
Wang HY; Cao PP; He ZY; He XW; Li WY; Li YH; Zhang YK
Nanoscale; 2019 Sep; 11(36):17018-17030. PubMed ID: 31502627
[TBL] [Abstract][Full Text] [Related]
17. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
[TBL] [Abstract][Full Text] [Related]
18. Multiple presentation of Scfv800E6 on silica nanospheres enhances targeting efficiency toward HER-2 receptor in breast cancer cells.
Mazzucchelli S; Verderio P; Sommaruga S; Colombo M; Salvadè A; Corsi F; Galeffi P; Tortora P; Prosperi D
Bioconjug Chem; 2011 Nov; 22(11):2296-303. PubMed ID: 22010849
[TBL] [Abstract][Full Text] [Related]
19. DNA-affibody nanoparticles for inhibiting breast cancer cells overexpressing HER2.
Zhang Y; Jiang S; Zhang D; Bai X; Hecht SM; Chen S
Chem Commun (Camb); 2017 Jan; 53(3):573-576. PubMed ID: 27975087
[TBL] [Abstract][Full Text] [Related]
20. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Basile I; Maynadier M; Vaillant O; Mongin O; Blanchard-Desce M; Morère A; Garcia M; Durand JO; Raehm L
Angew Chem Int Ed Engl; 2011 Nov; 50(48):11425-9. PubMed ID: 21976357
[No Abstract] [Full Text] [Related]
[Next] [New Search]
